Historical Valuation
PAVmed Inc (PAVM) is now in the Fair zone, suggesting that its current forward PS ratio of 22.97 is considered Fairly compared with the five-year average of -2.73. The fair price of PAVmed Inc (PAVM) is between 3.85 to 17.30 according to relative valuation methord.
Relative Value
Fair Zone
3.85-17.30
Current Price：7.29
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
PAVmed Inc (PAVM) has a current Price-to-Book (P/B) ratio of 0.67. Compared to its 3-year average P/B ratio of -0.62 , the current P/B ratio is approximately -207.40% higher. Relative to its 5-year average P/B ratio of -12.43, the current P/B ratio is about -105.36% higher. PAVmed Inc (PAVM) has a Forward Free Cash Flow (FCF) yield of approximately -53.04%. Compared to its 3-year average FCF yield of -269.20%, the current FCF yield is approximately -80.30% lower. Relative to its 5-year average FCF yield of -174.66% , the current FCF yield is about -69.63% lower.
P/B
Median3y
-0.62
Median5y
-12.43
FCF Yield
Median3y
-269.20
Median5y
-174.66
Competitors Valuation Multiple
AI Analysis for PAVM
The average P/S ratio for PAVM competitors is 4.78, providing a benchmark for relative valuation. PAVmed Inc Corp (PAVM.O) exhibits a P/S ratio of 22.97, which is 380.39% above the industry average. Given its robust revenue growth of -99.50%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for PAVM
1Y
3Y
5Y
Market capitalization of PAVM increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of PAVM in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is PAVM currently overvalued or undervalued?
PAVmed Inc (PAVM) is now in the Fair zone, suggesting that its current forward PS ratio of 22.97 is considered Fairly compared with the five-year average of -2.73. The fair price of PAVmed Inc (PAVM) is between 3.85 to 17.30 according to relative valuation methord.
What is PAVmed Inc (PAVM) fair value?
PAVM's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of PAVmed Inc (PAVM) is between 3.85 to 17.30 according to relative valuation methord.
How does PAVM's valuation metrics compare to the industry average?
The average P/S ratio for PAVM's competitors is 4.78, providing a benchmark for relative valuation. PAVmed Inc Corp (PAVM) exhibits a P/S ratio of 22.97, which is 380.39% above the industry average. Given its robust revenue growth of -99.50%, this premium appears unsustainable.
What is the current P/B ratio for PAVmed Inc (PAVM) as of Jan 10 2026?
As of Jan 10 2026, PAVmed Inc (PAVM) has a P/B ratio of 0.67. This indicates that the market values PAVM at 0.67 times its book value.
What is the current FCF Yield for PAVmed Inc (PAVM) as of Jan 10 2026?
As of Jan 10 2026, PAVmed Inc (PAVM) has a FCF Yield of -53.04%. This means that for every dollar of PAVmed Inc’s market capitalization, the company generates -53.04 cents in free cash flow.
What is the current Forward P/E ratio for PAVmed Inc (PAVM) as of Jan 10 2026?
As of Jan 10 2026, PAVmed Inc (PAVM) has a Forward P/E ratio of -0.43. This means the market is willing to pay $-0.43 for every dollar of PAVmed Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for PAVmed Inc (PAVM) as of Jan 10 2026?
As of Jan 10 2026, PAVmed Inc (PAVM) has a Forward P/S ratio of 22.97. This means the market is valuing PAVM at $22.97 for every dollar of expected revenue over the next 12 months.